Skip to main content
Log in

Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Monovariate and multivariate analyses including logistic regression were performed to determine associations among predicting variables [age, gender, immunofluorescence pattern, and anti-nuclear antibody (ANA) titer] and anti-extractable nuclear antigen (ENA) and -dsDNA antibodies (Abs) in 1089 patients with positive fluorescent ANA (FANA) test results. Samples with high titer ANAs had an increased frequency of anti-ENA and -dsDNA Abs. The receiver operating (ROC) curves of the ANA titer for anti-ENA Abs had a larger under the curve area compared to the ROC curve for anti-dsDNA Abs, indicating that ANA titer is better for predicting anti-ENA Abs than anti-dsDNA Abs. There was no relation noticed between immunofluorescence patterns and anti-ENA and -dsDNA Abs except an increased frequency of anti-dsDNA Abs found in samples with a homogeneous pattern. Probability calculations on the basis of the ANA pattern and the titer showed that samples with low titer ANAs (1:160 or less) had low probabilities for anti-ENA Abs (0.002–0.009) regardless of immunofluorescence patterns. However, samples with a homogeneous pattern at any titers including low titers had high probabilities for anti-dsDNA Abs. A decreased frequency of anti-dsDNA Abs as measured by Crithidia assay was noticed in samples from patients aged 50 or older. In contrast, no association was noticed between age and anti-ENA Abs. There was no female preponderance found in the presence of anti-ENA and -dsDNA Abs. In conclusion, our study shows that the ANA titer but not the immunofluorescence pattern is useful in predicting anti-ENA Abs. In contrast, both the ANA titer and the immunofluorescence pattern help in predicting anti-dsDNA Abs. Samples with low titer ANAs (1:160 or less) may not need a further test for anti-ENA Abs unless an ANA-associated disease is highly suspected. However, a test for anti-dsDNA Abs should be considered in samples with a homogeneous pattern at any titer including low titers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Brown BW (1980) Prediction analyses for binary data. In: Miller RG, Efron B, Brown BW, Moses LE (eds) Biostatistics casebook. John Wiley and Sons, New York

  2. Craig WY, Ledue TB, Johnson AM, Ritchie RF (1999) The distribution of antinuclear antibody titers in “normal” children and adults. J Rheumatol 26:914–919

    CAS  PubMed  Google Scholar 

  3. de Vlam K, De Keyser F, Verbruggen G, et al. (1993) Detection and identification of antinuclear autoantibodies in the serum of normal blood donors. Clin Exp Rheumatol 11:393–397

    PubMed  Google Scholar 

  4. Homburger HA (1995) Cascade testing for autoantibodies in connective tissue diseases. Mayo Clin Proc 70:183–184

    CAS  PubMed  Google Scholar 

  5. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA (2000) Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 124:71–81

    CAS  PubMed  Google Scholar 

  6. Malleson PN, Sailer M, Mackinnon MJ (1997) Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch Dis Child 77:299–304

    CAS  PubMed  Google Scholar 

  7. Peene I, Meheus L, Veys EM, De Keyser F (2001) Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 60:1131–1136

    Article  CAS  PubMed  Google Scholar 

  8. Peng SL, Hardin JA, Craft J (1997) Antinuclear antibodies. In: Kelly WN, Harris ED Jr, Ruddy S, Sledge CB (eds) Text book of rheumatology. WB Saunders, Philadelphia, pp 250–266

  9. Vaile JH, Dyke L, Kherani R, Johnston C, Higgins T, Russell AS (2000) Is high titre ANA specific for connective tissue disease? Clin Exp Rheumatol 18:433–438

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Insoo Kang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kang, I., Siperstein, R., Quan, T. et al. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies. Clin Rheumatol 23, 509–515 (2004). https://doi.org/10.1007/s10067-004-0937-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-004-0937-0

Keywords

Navigation